Seryx Biomedical, Inc.
Seryx Biomedical has developed a novel, protein-based ophthalmic solution for the treatment of dry eye disease.
Seryx Biomedical is a start up company developing a novel eye drop for the treatment of dry eye disease which affects over 75M people worldwide. Silk fibroin is the main component of the ViSERA™ eye drop, capitalizing on its properties of an anti-inflammatory, pro-healing, protein network which will stabilize the natural tear film and improve ocular comfort. Over 40,000 eye care specialists will prescribe our products to their patients.